Treatment approaches for managing patients with hematological malignancies in the time of COVID-19 pandemic
TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.6, ss.2799-2809, 2021 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 51 Sayı: 6
- Basım Tarihi: 2021
- Doi Numarası: 10.3906/sag-2101-276
- Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.2799-2809
- Anahtar Kelimeler: COVID-19, SARS-CoV-2, hematological malignancies, HIGH-DOSE CHEMOTHERAPY, MULTIPLE-MYELOMA, BREAST-CANCER, LEUKEMIA, MARROW, TRANSPLANTATION, GUIDELINES, MANAGEMENT, RISK
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Ankara Üniversitesi Adresli: Evet
Özet
Background/aim: The COVID-19 pandemic is a unique challenge to the care of patients with hematological malignancies. We aim to provide supportive guidance to clinicians making individual patients decisions during the COVID-19 pandemic, in particular during periods that access to healthcare resources may be limited.